Victory Capital Management
ABEO icon

Victory Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Victory Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-760
Closed -$4K – 2697
2022
Q2 		$4K Buy
760
+30
+4% +$152 ﹤0.01% 2683
2022
Q1 		$4K Sell
730
-62
-8% -$426 ﹤0.01% 2711
2021
Q4 		$7K Buy
792
+258
+48% +$4.74K ﹤0.01% 2744
2021
Q3 		$15K Sell
534
-9
-2% -$288 ﹤0.01% 2741
2021
Q2 		$21K Sell
543
-20
-4% -$816 ﹤0.01% 2706
2021
Q1 		$26K Sell
563
-18
-3% -$992 ﹤0.01% 2707
2020
Q4 		$23K Buy
581
+117
+25% +$3.98K ﹤0.01% 2500
2020
Q3 		$12K Sell
464
-9
-2% -$567 ﹤0.01% 2456
2020
Q2 		$34K Sell
473
-429
-48% -$29.7K ﹤0.01% 2415
2020
Q1 		$48K Buy
+902
New +$60.2K ﹤0.01% 2771
2019
Q4 		– Sell
-188
Closed -$11K – 2627
2019
Q3 		$11K Buy
188
+145
+337% +$10.9K ﹤0.01% 3214
2019
Q2 		$5K Hold
43
– – ﹤0.01% 1816
2019
Q1 		$8K Hold
43
– – ﹤0.01% 1766
2018
Q4 		$8K Hold
43
– – ﹤0.01% 1771
2018
Q3 		$14K Buy
43
+6
+16% +$2.13K ﹤0.01% 1776
2018
Q2 		$15K Hold
37
– – ﹤0.01% 1804
2018
Q1 		$13K Buy
+37
New +$13.7K ﹤0.01% 1803

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management's ABEO Position: Q3 2022 in Review

Victory Capital Management sold out of Abeona Therapeutics (ABEO) in Q3 2022, closing a stake of 760 shares — an estimated $4K sold.

Victory Capital Management first reported a position in ABEO in Q1 2018 and held it in 17 quarters. The position peaked at $48K in Q1 2020. 24 funds tracked by Wall St. Rank hold ABEO as of Q3 2022.

  • Victory Capital Management reported no remaining Abeona Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Victory Capital Management sold 760 Abeona Therapeutics shares in Q3 2022, an estimated $4K.
  • Victory Capital Management first reported a position in Abeona Therapeutics in Q1 2018 and held it in 17 quarters.
  • Victory Capital Management's Abeona Therapeutics position peaked at $48K in Q1 2020.
  • 24 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.